CompanyDeals

Jiangsu Aidea Pharmaceutical Partners with Fidson Healthcare for HIV/AIDS Treatments in Nigeria

CompanyDeals

GE Healthcare’s Shanghai Innovation Hub Onboards Initial Start-Ups

CompanyDrug

BeiGene’s Brukinsa Secures Additional EU Approval for Follicular Lymphoma Treatment

CompanyDeals

WuXi Biologics’ Subsidiary WuXi XDC Lists on Hong Kong Stock Exchange

CompanyDeals

Winning Health Partners with Shanghai Seventh People’s Hospital on Medical AI Services

CompanyDeals

Thermo Fisher Scientific Expands Partnership with Sangon Biotech to Include GC/MS

CompanyDeals

Usynova Pharmaceuticals Inks Licensing Deal with AstraZeneca for KRASG12D Inhibitor UA022

CompanyDrug

Ascentage Pharma Secures Additional Indication Approval for Olverembatinib from NMPA

Company

Aurobindo Pharma’s China Plant Secures EU GMP Approval, Eyes Revenue Generation

CompanyDrug

CSPC Pharmaceutical Group Receives NMPA Approval for Phase II Clinical Study of ALMB-0168

CompanyDrug

Apollomics’ Partner Avistone Wins Conditional Approval for c-Met Inhibitor in China

CompanyDrug

Fosun Pharmaceutical Secures Clinical Trial Approvals for VT-101 in China and the US